Alpha 2.0
Login Register
» Articles » PMID: 19374533

Calcium Phosphate Nanocomposite Particles: a Safer and More Effective Alternative to Conventional Chemotherapy?

Overview
Journal Future Oncol
Specialty Oncology
Date 2009 Apr 21
PMID 19374533
Citations 4
Authors
Erhan I Altinoglu
James H Adair
Affiliations
Soon will be listed here.
Citing Articles

CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery.

Abraham T, Armold M, McGovern C, Harms J, Darok M, Gigliotti C Biomedicines. 2024; 12(5).

PMID: 38790986 PMC: 11118934. DOI: 10.3390/biomedicines12051024.

PD-L1-Targeted Co-Delivery of Two Chemotherapeutics for Efficient Suppression of Skin Cancer Growth.

Movahedi F, Liu J, Sun B, Cao P, Sun L, Howard C Pharmaceutics. 2022; 14(7).

PMID: 35890381 PMC: 9318418. DOI: 10.3390/pharmaceutics14071488.

Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.

Loc W, Linton S, Wilczynski Z, Matters G, McGovern C, Abraham T Nanomedicine. 2017; 13(7):2313-2324.

PMID: 28673852 PMC: 5625839. DOI: 10.1016/j.nano.2017.06.017.

PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate.

Barth B, Shanmugavelandy S, Kaiser J, McGovern C, Altinoglu E, Haakenson J ACS Nano. 2013; 7(3):2132-44.

PMID: 23373542 PMC: 3757127. DOI: 10.1021/nn304862b.